BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16827082)

  • 41. The presence of dental disease can be a risk factor for recurrent Helicobacter pylori infection after eradication therapy: a 3-year follow-up.
    Sheu BS; Cheng HC; Yang YJ; Yang HB; Wu JJ
    Endoscopy; 2007 Nov; 39(11):942-7. PubMed ID: 17886199
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term clinical outcome of helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma is comparable to that of h. pylori-positive lymphoma.
    Chung SJ; Kim JS; Kim H; Kim SG; Kim CW; Jung HC; Song IS
    J Clin Gastroenterol; 2009 Apr; 43(4):312-7. PubMed ID: 18936712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Helicobacter pylori genotypes in children from a population at high gastric cancer risk: no association with gastroduodenal histopathology.
    Lopes AI; Palha A; Monteiro L; Olcastro M; Pelerito A; Fernandes A
    Am J Gastroenterol; 2006 Sep; 101(9):2113-22. PubMed ID: 16848806
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nodular gastritis in adults: clinical features, endoscopic appearance, histopathological features, and response to therapy.
    Dwivedi M; Misra SP; Misra V
    J Gastroenterol Hepatol; 2008 Jun; 23(6):943-7. PubMed ID: 17614956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer.
    Ogura K; Hirata Y; Yanai A; Shibata W; Ohmae T; Mitsuno Y; Maeda S; Watabe H; Yamaji Y; Okamoto M; Yoshida H; Kawabe T; Omata M
    J Clin Gastroenterol; 2008 Mar; 42(3):279-83. PubMed ID: 18223496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Age and eradication treatment of duodenal ulcer].
    Minushkin ON; Volodin DV; Zverkov IV; Ivanova OI; Shuleshova AG; Burdina EG
    Ter Arkh; 2007; 79(2):22-6. PubMed ID: 17460963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis.
    Hershko C; Ianculovich M; Souroujon M
    Acta Haematol; 2007; 118(1):19-26. PubMed ID: 17426393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between interleukin-1 gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in a Chinese population.
    Li C; Xia HH; Xie W; Hu Z; Ye M; Li J; Cheng H; Zhang X; Xia B
    J Gastroenterol Hepatol; 2007 Feb; 22(2):234-9. PubMed ID: 17295877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
    Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of 4 laboratory methods for detection of Helicobacter pylori.
    Al-Humayed SM; Ahmed ME; Bello CS; Tayyar MA
    Saudi Med J; 2008 Apr; 29(4):530-2. PubMed ID: 18382793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of myeloperoxidase -463 G/A polymorphism with clinical outcome of Helicobacter pylori infection in Iranian patients with gastrointestinal diseases.
    Kamali-Sarvestani E; Farsiani H; Shamoon Pour M; Bazargani A; Lankarani K; Taghavi AR; Saberifiroozi M
    Iran J Immunol; 2007 Sep; 4(3):155-60. PubMed ID: 17767014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of Helicobacter pylori and determination of clarithromycin susceptibility using formalin-fixed, paraffin-embedded gastric biopsy specimens by fluorescence in situ hybridization.
    Yilmaz O; Demiray E; Tümer S; Altungöz O; Yörükoğlu K; Soytürk M; Simşek I
    Helicobacter; 2007 Apr; 12(2):136-41. PubMed ID: 17309750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The conditions of Helicobacter pylori colonization in different gastric diseases].
    Liu YE; Yu XW; Dong NN; Gong YH; Sun LP; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):230-2. PubMed ID: 18361831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Helicobacter pylori cagA, vacA and iceA genotypes in western Indian population of Maharashtra with varied gastroduodenal diseases.
    Dharne MS; Munot H; Pujari R; Kakrani AL; Patole MS; Shouche YS
    Indian J Pathol Microbiol; 2007 Oct; 50(4):740-8. PubMed ID: 18306540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteomic identification of biomarkers related to Helicobacter pylori-associated gastroduodenal disease: challenges and opportunities.
    Wu MS; Chow LP; Lin JT; Chiou SH
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1657-61. PubMed ID: 19120858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.
    Katsinelos P; Tziomalos K; Chatzimavroudis G; Vasiliadis T; Katsinelos T; Pilpilidis I; Triantafillidis I; Paroutoglou G; Papaziogas B
    Med Princ Pract; 2007; 16(2):119-23. PubMed ID: 17303947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.